{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:03:18Z","timestamp":1790024598257,"version":"4.0.1"},"reference-count":269,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1053\/j.sult.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T16:08:34Z","timestamp":1680710914000},"page":"469-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies"],"prefix":"10.1053","volume":"44","author":[{"given":"Jo\u00e3o Vitor Gerdulli","family":"Tamanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Alves","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Mizubuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano de Lima","family":"Villarinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana \u00c1vila","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Veloso","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0001","first-page":"1","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: Current insights into the disease pathophysiology, diagnosis and management","volume":"22","author":"Ambrosius","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 A review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"issue":"Suppl 6","key":"10.1053\/j.sult.2023.03.017_bib0003","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0004","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: Clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2017.12.015","article-title":"Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis","volume":"20","author":"Harirchian","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: Risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: An updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.sult.2023.03.017_bib0008","doi-asserted-by":"crossref","unstructured":"Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: From pathophysiology to therapeutic strategies. https:\/\/doi.org\/10.1186\/s12974-021-02249-1","DOI":"10.1186\/s12974-021-02249-1"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin Med (Lond)"},{"issue":"9451","key":"10.1053\/j.sult.2023.03.017_bib0010","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0011","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archneurol.2012.249","article-title":"Effects of age and sex on Aquaporin-4 autoimmunity","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0012","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0014","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/jnnp.2004.055491","article-title":"Gluten sensitivity and neuromyelitis optica: Two case reports","volume":"76","author":"Jacob","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"10.1053\/j.sult.2023.03.017_bib0015","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2023.03.017_bib0016","doi-asserted-by":"crossref","unstructured":"DM Wingerchuk, B Banwell, JL Bennett, et al., VIEWS & REVIEWS International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, 85 (2), 177-189.","DOI":"10.1212\/WNL.0000000000001729"},{"issue":"9","key":"10.1053\/j.sult.2023.03.017_bib0017","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0018","author":"Takai"},{"issue":"21","key":"10.1053\/j.sult.2023.03.017_bib0019","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1053\/j.sult.2023.03.017_bib0020","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: A UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ana.25909","article-title":"Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"89","author":"Cobo-Calvo","year":"2021","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0022","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0023","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: A comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0024","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"9 Suppl 2","key":"10.1053\/j.sult.2023.03.017_bib0025","first-page":"S38","article-title":"Acute disseminated encephalomyelitis updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0026","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndromes: Incidence, clinical and magnetic resonance imaging features","volume":"19","author":"Absoud","year":"2013","journal-title":"Mult Scler"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0027","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","article-title":"Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients","volume":"59","author":"Tenembaum","year":"2002","journal-title":"Neurology"},{"issue":"16 Suppl 2","key":"10.1053\/j.sult.2023.03.017_bib0028","first-page":"S23","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2023.03.017_bib0029","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/B978-0-444-52910-7.00048-9","article-title":"Acute disseminated encephalomyelitis","volume":"112","author":"Tenembaum","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","article-title":"Diagnosis and management of acute myelopathies","volume":"11","author":"Kaplin","year":"2005","journal-title":"Neurologist"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0032","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.reuma.2016.06.004","article-title":"Myelitis and lupus: Clinical manifestations, diagnosis and treatment. Review","volume":"13","author":"Chiganer","year":"2017","journal-title":"Reumatol Clin"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0033","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus. Epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0034","first-page":"323","article-title":"Transverse myelopathy in systemic lupus erythematosus","volume":"60","author":"Thakarar","year":"1979","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2010.03208.x","article-title":"Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation","volume":"18","author":"Katsiari","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0036","doi-asserted-by":"crossref","unstructured":"Saison J, Costedoat-Chalumeau N, Maucort-Boulch D, et al. Systemic lupus erythematosus-associated acute transverse myelitis: Manifestations, treatments, outcomes, and prognostic factors in 20 patients. 2014;24(1):74-81. https:\/\/doi.org\/10.1177\/0961203314547795","DOI":"10.1177\/0961203314547795"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0037","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0038","first-page":"736","article-title":"Statement on Sarcoidosis","volume":"160","author":"Hunninghake","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0039","article-title":"Racial differences in sarcoidosis incidence: A 5-year study in a Health Maintenance Organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol Copyright O"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir Med"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0741-x","article-title":"Clinical features, treatment and outcome in neurosarcoidosis: Systematic review and meta-analysis","volume":"16","author":"Fritz","year":"2016","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0042","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/ene.15295","article-title":"Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature","volume":"29","author":"Nolte","year":"2022","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","article-title":"Primary Sj\u00f6gren's syndrome and the eye","volume":"65","author":"Bjordal","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0044","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","article-title":"Neurologic manifestations of primary Sj\u00f6gren syndrome","volume":"43","author":"Margaretten","year":"2017","journal-title":"Rheumatic Dis Clin N Am"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sj\u00f6gren's syndrome","volume":"56","author":"Perzy\u0144ska-Mazan","year":"2018","journal-title":"Reumatologia"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0046","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2013-000651","article-title":"The neurology of Sj\u00f6gren's syndrome and the rheumatology of peripheral neuropathy and myelitis","volume":"14","author":"Berkowitz","year":"2014","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0047","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9343(02)01380-3","article-title":"Sj\u00f6gren's syndrome-associated myelopathy: Response to immunosuppressive treatment","volume":"114","author":"Vincent","year":"2003","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0048","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/1352458515613642","article-title":"Spinal cord involvement in Beh\u00e7et's disease","volume":"22","author":"Lee","year":"2016","journal-title":"Multiple Sclerosis"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0049","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.25004","article-title":"Myelopathy in Beh\u00e7et's disease: The Bagel sign","volume":"82","author":"Uygunoglu","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0050","doi-asserted-by":"crossref","unstructured":"Ur U\u02d8, Lu U\u02d8, Pasha M, et al. Case report recurrent longitudinal extensive transverse myelitis in a neuro-Beh\u00e7et syndrome treated with infliximab. https:\/\/doi.org\/10.1179\/2045772314Y.0000000209","DOI":"10.1179\/2045772314Y.0000000209"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0051","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3315\/jdcr.2015.1213","article-title":"Beh\u00e7et's disease in black skin. A retrospective study of 50 cases in Dakar","volume":"9","author":"Ndiaye","year":"2015","journal-title":"J Dermatol Case Rep"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0052","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/kes249","article-title":"Incidence, prevalence and clinical characteristics of Beh\u00e7et's disease in southern Sweden","volume":"52","author":"Mohammad","year":"2013","journal-title":"Rheumatology"},{"key":"10.1053\/j.sult.2023.03.017_bib0053","author":"Krause"},{"key":"10.1053\/j.sult.2023.03.017_bib0054","unstructured":"Kappen JH, Van Dijk EHC, Baak-Dijkstra M, et al. 2015. Beh\u00e7et's disease, hospital-based prevalence and manifestations in the Rotterdam area."},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Beh\u00e7et's disease: Diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0056","doi-asserted-by":"crossref","unstructured":"Amato MP, Derfuss T, Hemmer B, et al. Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. 2017;24(5):590-603. https:\/\/doi.org\/10.1177\/1352458516686847","DOI":"10.1177\/1352458516686847"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0057","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","article-title":"Multiple sclerosis-a quiet revolution","volume":"11","author":"Ransohoff","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0058","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","article-title":"Genetics of multiple sclerosis","volume":"3","author":"Dyment","year":"2004","journal-title":"Lancet Neurology"},{"issue":"7359","key":"10.1053\/j.sult.2023.03.017_bib0059","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0060","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0061","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0062","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"issue":"6578","key":"10.1053\/j.sult.2023.03.017_bib0063","first-page":"296","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (1979)"},{"key":"10.1053\/j.sult.2023.03.017_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103636","article-title":"Is EBV the cause of multiple sclerosis?","volume":"58","author":"Giovannoni","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2023.03.017_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/B978-0-12-386960-9.00018-6","article-title":"Vitamin D as a T-cell modulator in multiple sclerosis","volume":"86","author":"Smolders","year":"2011","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0066","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1352458514546785","article-title":"Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study","volume":"21","author":"Wesnes","year":"2015","journal-title":"Mult Scler"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0067","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"9648","key":"10.1053\/j.sult.2023.03.017_bib0068","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1053\/j.sult.2023.03.017_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367614","article-title":"New multiple sclerosis phenotypic classification","volume":"72","author":"Lublin","year":"2014","journal-title":"Eur Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0070","doi-asserted-by":"crossref","unstructured":"Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. 2016;9(3):260-274. https:\/\/doi.org\/10.1191\/1352458503MS914OA","DOI":"10.1191\/1352458503ms914oa"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0071","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: Pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0072","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0073","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","article-title":"Primary-progressive multiple sclerosis","volume":"6","author":"Miller","year":"2007","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0074","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10076","key":"10.1053\/j.sult.2023.03.017_bib0075","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: Progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.sult.2023.03.017_bib0076","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00415-020-09930-0","article-title":"Diagnosis and management of multiple sclerosis: MRI in clinical practice","volume":"267","author":"Tomassini","year":"2020","journal-title":"J Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0077","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285613478870","article-title":"Neuroradiological evaluation of demyelinating disease","volume":"6","author":"Tillema","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102801","article-title":"Pediatric inflammatory demyelinating disorders and mimickers: How to differentiate with MRI?","volume":"20","author":"Pereira","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0079","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.62.2.226","article-title":"Spinal cord abnormalities in recently diagnosed MS patients","volume":"62","author":"Bot","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0081","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1148\/radiol.11101362","article-title":"MR imaging of multiple sclerosis","volume":"259","author":"Filippi","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2023.03.017_bib0082","doi-asserted-by":"crossref","unstructured":"Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. 1995;195(3):725-732. https:\/\/doi.org\/10.1148\/RADIOLOGY.195.3.7754002","DOI":"10.1148\/radiology.195.3.7754002"},{"issue":"9","key":"10.1053\/j.sult.2023.03.017_bib0083","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","article-title":"Spinal-cord MRI in multiple sclerosis","volume":"2","author":"Lycklama","year":"2003","journal-title":"Lancet Neurol"},{"issue":"2B","key":"10.1053\/j.sult.2023.03.017_bib0084","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1590\/S0004-282X2004000300010","article-title":"The pattern of proton magnetic resonance spectroscopy in non-neoplastic encephalic lesions","volume":"62","author":"Faria","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/iim.13.49","article-title":"Diffusion tensor MRI as a biomarker in axonal and myelin damage","volume":"5","author":"Aung","year":"2013","journal-title":"Imaging Med"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0086","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.26281","article-title":"Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis","volume":"91","author":"Bischof","year":"2022","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0087","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0088","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0089","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4\u2013binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J Exp Med"},{"issue":"9","key":"10.1053\/j.sult.2023.03.017_bib0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0091","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"28","author":"Mader","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0092","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","article-title":"The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody","volume":"139","author":"H\u00f6ftberger","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04332-3","article-title":"A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica","volume":"9","author":"Estrada","year":"2018","journal-title":"Nature Commun"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1551-z","article-title":"Next-generation sequencing identifies contribution of both class i and II HLA genes on susceptibility of multiple sclerosis in Japanese","volume":"16","author":"Ogawa","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/NXI.0000000000000702","article-title":"HLA association in MOG-IgG\u2013 and AQP4-IgG\u2013related disorders of the CNS in the Dutch population","volume":"7","author":"Bruijstens","year":"2020","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0096","article-title":"HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS\/NMOSD Biobank data","volume":"11","author":"Watanabe","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"10.1053\/j.sult.2023.03.017_bib0097","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1352458517731914","article-title":"Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2023.03.017_bib0098","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.msard.2019.03.031","article-title":"Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series","volume":"31","author":"Bernard-Valnet","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0099","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-017-0594-z","article-title":"The gut microbiome in neuromyelitis optica","volume":"15","author":"Zamvil","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1053\/j.sult.2023.03.017_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102474","article-title":"Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report","volume":"46","author":"de Ruijter","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"Pt 7","key":"10.1053\/j.sult.2023.03.017_bib0101","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica: An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0103","doi-asserted-by":"crossref","unstructured":"Kim W, Min Su Park, Sang Hyun Lee, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. 2010;16(10):1229-1236. https:\/\/doi.org\/10.1177\/1352458510376640","DOI":"10.1177\/1352458510376640"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0104","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp.2008.168070","article-title":"Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica","volume":"81","author":"de Seze","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0105","first-page":"1009","article-title":"Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica","volume":"27","author":"Yu","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0106","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.neuroimage.2011.11.022","article-title":"Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques","volume":"59","author":"Zhao","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiol.12111241","article-title":"The role of demyelination in neuromyelitis optica damage: Diffusion-tensor MR imaging study","volume":"263","author":"Lopes","year":"2012","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0108","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00234-016-1738-2","article-title":"Spinal cord diffusion tensor imaging in patients with sensory neuronopathy","volume":"58","author":"Casseb","year":"2016","journal-title":"Neuroradiology"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"H\u00f6ftberger","year":"2015","journal-title":"Mult Scler"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2023.03.017_bib0111","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3389\/fimmu.2021.769653","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease and varicella zoster virus infection - Frequency of an Association","volume":"12","author":"di Pauli","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5692\/clinicalneurol.cn-001066","article-title":"Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive varicella-zoster virus myelitis presenting as longitudinally extensive transverse myelitis: A case report","volume":"57","author":"Shiga","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-014-0224-x","article-title":"Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: A case report","volume":"14","author":"Amano","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0114","doi-asserted-by":"crossref","unstructured":"Vieira JP, Sequeira J, Brito MJ. Postinfectious anti\u2013myelin oligodendrocyte glycoprotein antibody positive optic neuritis and myelitis. 2017;32(12):996-999. https:\/\/doi.org\/10.1177\/0883073817724927","DOI":"10.1177\/0883073817724927"},{"key":"10.1053\/j.sult.2023.03.017_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.msard.2017.07.023","article-title":"A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection","volume":"17","author":"Nakamura","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0116","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: A case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Internal Medicine"},{"key":"10.1053\/j.sult.2023.03.017_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.578011","article-title":"Atypical myelin oligodendrocyte glycoprotein antibody\u2013associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review","volume":"375","author":"Bosello","year":"2023","journal-title":"J Neuroimmunol"},{"key":"10.1053\/j.sult.2023.03.017_bib0118","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review","volume":"26","author":"Assavapongpaiboon","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1053\/j.sult.2023.03.017_bib0119","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.845755","article-title":"MOG antibody-associated disorders following SARS-CoV-2 vaccination: A case report and literature review","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front Neurol"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2169\/internalmedicine.0504-22","article-title":"Relapsing Anti-MOG antibody-associated disease following COVID-19 Vaccination: A rare case report and review of the literature","volume":"62","author":"Nakano","year":"2023","journal-title":"Internal Med"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0121","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): Case report and comprehensive review of the literature","volume":"269","author":"Jarius","year":"2022","journal-title":"J Neurol"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0122","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/acn3.51378","article-title":"No strong HLA association with MOG antibody disease in the UK population","volume":"8","author":"Grant-Peters","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102399","article-title":"Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica","volume":"45","author":"Ciotti","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0124","first-page":"1","article-title":"MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1053\/j.sult.2023.03.017_bib0125","doi-asserted-by":"crossref","unstructured":"Shahriari M, Sotirchos ES, Newsome SD, et al. MOGAD: how it differs from and resembles other neuroinflammatory disorders. 2021;216(4):1031-1039. https:\/\/doi.org\/10.2214\/AJR.20.24061","DOI":"10.2214\/AJR.20.24061"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0126","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J Neuroradiol"},{"key":"10.1053\/j.sult.2023.03.017_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102759","article-title":"FLAMES: A novel burning entity in MOG IgG associated disease","volume":"49","author":"Jain","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2023.03.017_bib0128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2019.06.017","article-title":"Acute disseminated encephalomyelitis in children: An updated review based on current diagnostic criteria","volume":"100","author":"Cole","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0031-1271656","article-title":"Acute disseminated encephalomyelitis: A long-term prospective study and meta-analysis","volume":"41","author":"Pavone","year":"2010","journal-title":"Neuropediatrics"},{"issue":"9","key":"10.1053\/j.sult.2023.03.017_bib0130","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/jnnp-2020-323678","article-title":"COVID-19\u2013associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network","volume":"91","author":"Delamarre","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1053\/j.sult.2023.03.017_bib0131","article-title":"Acute disseminated encephalomyelitis (ADEM) associated with COVID-19","volume":"13","author":"Langley","year":"2020","journal-title":"BMJ Case Reports CP"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0132","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00415-020-09951-9","article-title":"COVID-19-associated acute disseminated encephalomyelitis (ADEM)","volume":"267","author":"Parsons","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02166-2","article-title":"Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology","volume":"140","author":"Reichard","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102753","article-title":"Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement","volume":"20","author":"Shahmirzaei","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.26182","article-title":"Postvaccinal Encephalitis after ChAdOx1 nCov-19","volume":"90","author":"Zuhorn","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0136","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.msard.2017.09.018","article-title":"Short term outcome of ADEM: Results from a retrospective cohort study from South India","volume":"18","author":"Iype","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0137","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00415-018-8835-6","article-title":"Incidence and outcome of acquired demyelinating syndromes in Dutch children: Update of a nationwide and prospective study","volume":"265","author":"de Mol","year":"2018","journal-title":"J Neurol"},{"issue":"19","key":"10.1053\/j.sult.2023.03.017_bib0138","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0000000000003318","article-title":"A nationwide survey of pediatric acquired demyelinating syndromes in Japan","volume":"87","author":"Yamaguchi","year":"2016","journal-title":"Neurology"},{"issue":"13","key":"10.1053\/j.sult.2023.03.017_bib0139","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1212\/01.wnl.0000316193.89691.e1","article-title":"Prognostic factors after a first attack of inflammatory CNS demyelination in children","volume":"71","author":"Neuteboom","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/dmcn.13798","article-title":"Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: A nationwide validation study","volume":"60","author":"Boesen","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0141","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2008.03.009","article-title":"Acute disseminated encephalomyelitis in children: Focus on relapsing patients","volume":"39","author":"Suppiej","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0142","first-page":"262","article-title":"Association between seasonal influenza vaccines and the increased risk of acute disseminated encephalomyelitis, estimated using the Vaccine Adverse Event Reporting System","volume":"77","author":"Fujimori","year":"2022","journal-title":"Pharmazie"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0143","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.braindev.2019.02.011","article-title":"Clinical time course of pediatric acute disseminated encephalomyelitis","volume":"41","author":"Nishiyama","year":"2019","journal-title":"Brain Dev"},{"issue":"12","key":"10.1053\/j.sult.2023.03.017_bib0144","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1469-8749.2007.00887.x","article-title":"Early relapse risk after a first CNS inflammatory demyelination episode: Examining international consensus definitions","volume":"49","author":"Dale","year":"2007","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2013.03.021","article-title":"Acute disseminated encephalomyelitis in children and adolescents: A single center experience","volume":"49","author":"Erol","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0146","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0032-1309309","article-title":"Acute disseminated encephalomyelitis in children: A single institution experience of 28 patients","volume":"43","author":"Hung","year":"2012","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0147","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pediatrneurol.2013.12.006","article-title":"Long-term neurocognitive outcome and quality of life in pediatric acute disseminated encephalomyelitis","volume":"50","author":"Suppiej","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0148","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciw607","article-title":"Acute demyelinating events following vaccines: A case-centered analysis","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infectious Dis"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0149","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/1352458510390068","article-title":"Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children","volume":"17","author":"Ketelslegers","year":"2011","journal-title":"Multiple Sclerosis Journal"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0150","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1177\/1352458510382554","article-title":"Severe acute disseminated encephalomyelitis: A paediatric intensive care population-based study","volume":"17","author":"Absoud","year":"2011","journal-title":"Mult Scler"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0151","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pediatrneurol.2004.03.008","article-title":"Neuropsychological outcome after acute disseminated encephalomyelitis: Impact of age at illness onset","volume":"31","author":"Jacobs","year":"2004","journal-title":"Pediatr Neurol"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0152","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/1352458512466317","article-title":"Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients","volume":"19","author":"Huppke","year":"2013","journal-title":"Multiple Sclerosis Journal"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejpn.2006.11.007","article-title":"Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse","volume":"11","author":"Mikaeloff","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0154","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2023.03.017_bib0155","doi-asserted-by":"crossref","unstructured":"Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. 2013;19(10):1261-1267. https:\/\/doi.org\/10.1177\/1352458513484547","DOI":"10.1177\/1352458513484547"},{"key":"10.1053\/j.sult.2023.03.017_bib0156","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-444-63432-0.00019-0","article-title":"Autoimmune myelopathies","volume":"133","author":"Flanagan","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0157","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1148\/rg.2020190196","article-title":"Intramedullary masses of the spinal cord: Radiologic-pathologic correlation","volume":"40","author":"Shih","year":"2020","journal-title":"Radiographics"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0158","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000338630.20412.45","article-title":"Role of MRI in the differentiation of ADEM from MS in children","volume":"72","author":"Callen","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0159","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1352458508098562","article-title":"Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: A single centre prospective study","volume":"15","author":"Atzori","year":"2009","journal-title":"Mult Scler"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00234-006-0164-2","article-title":"Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis","volume":"49","author":"Balasubramanya","year":"2007","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0161","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pediatrneurol.2010.12.007","article-title":"Neuropathologic correlates for diffusion tensor imaging in postinfectious encephalopathy","volume":"44","author":"Chen","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0162","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: Epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent Clin North Am"},{"key":"10.1053\/j.sult.2023.03.017_bib0163","doi-asserted-by":"crossref","unstructured":"Laustrup H, Voss A, Green A, Junker P. Occurrence of systemic lupus erythematosus in a Danish community: An 8-year prospective study. 2009;38(2):128-132. https:\/\/doi.org\/10.1080\/03009740802419073","DOI":"10.1080\/03009740802419073"},{"key":"10.1053\/j.sult.2023.03.017_bib0164","doi-asserted-by":"crossref","unstructured":"Pereira Vilar MJ, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). 2016;11(8):528-532. https:\/\/doi.org\/10.1191\/0961203302LU244XX","DOI":"10.1191\/0961203302lu244xx"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780380415","article-title":"The prevalence and incidence of systemic lupus erythematosus in Birmingham, England","volume":"38","author":"Johnson","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0166","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/ard.53.10.675","article-title":"Clinical features and race-specific incidence\/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients","volume":"53","author":"Hopkinson","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.sult.2023.03.017_bib0167","doi-asserted-by":"crossref","unstructured":"Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. 2016;15(5):308-318. https:\/\/doi.org\/10.1191\/0961203306LU2305XX","DOI":"10.1191\/0961203306lu2305xx"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0168","doi-asserted-by":"crossref","first-page":"A277","DOI":"10.1016\/j.autrev.2009.12.008","article-title":"The geoepidemiology of systemic lupus erythematosus","volume":"9","author":"Borchers","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0169","first-page":"1978","article-title":"Incidence and mortality of systemic lupus erythematosus in a Southern Chinese population, 2000\u20132006","volume":"35","author":"Mok","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1053\/j.sult.2023.03.017_bib0170","doi-asserted-by":"crossref","unstructured":"al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. 2009;18(5):465-473. https:\/\/doi.org\/10.1177\/0961203308100660","DOI":"10.1177\/0961203308100660"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0171","first-page":"715","article-title":"One year in review 2019: Systemic lupus erythematosus","volume":"37","author":"Zucchi","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1053\/j.sult.2023.03.017_bib0172","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1053\/j.sult.2023.03.017_bib0173","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0895-4356(02)00429-8","article-title":"Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history","volume":"55","author":"Cooper","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0174","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.10368","article-title":"Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern United States","volume":"46","author":"Parks","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.2005.039438","article-title":"Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus","volume":"65","author":"Freemer","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0176","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.11105","article-title":"Sex hormones and systemic lupus erythematosus: Review and meta-analysis","volume":"48","author":"McMurray","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0177","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: A critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0178","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3899\/jrheum.090829","article-title":"Pancreatitis in systemic lupus erythematosus: Frequency and associated factors \u2014 A review of the Hopkins Lupus Cohort","volume":"37","author":"Makol","year":"2010","journal-title":"J Rheumatol"},{"issue":"OCT","key":"10.1053\/j.sult.2023.03.017_bib0179","first-page":"747","article-title":"Protein losing enteropathy in systemic lupus erythematosus","volume":"61","author":"Murali","year":"2013","journal-title":"J Assocf Phys India"},{"key":"10.1053\/j.sult.2023.03.017_bib0180","doi-asserted-by":"crossref","unstructured":"Quadrelli SA, Alvarez C, Arce SC, et al. Pulmonary involvement of systemic lupus erythematosus: Analysis of 90 necropsies. 2009;18(12):1053-1060. https:\/\/doi.org\/10.1177\/0961203309106601","DOI":"10.1177\/0961203309106601"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0181","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semarthrit.2003.09.006","article-title":"Pulmonary hemorrhage in systemic lupus erythematosus","volume":"33","author":"Badsha","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0182","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0049-0172(90)90094-V","article-title":"A long-term study of interstitial lung disease in systemic lupus erythematosus","volume":"20","author":"Weinrib","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.sult.2023.03.017_bib0183","first-page":"1","article-title":"Cardiac manifestations of rheumatological conditions: A narrative review","volume":"2012","author":"Owlia","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"12","key":"10.1053\/j.sult.2023.03.017_bib0184","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","article-title":"The management of peripheral blood cytopenias in systemic lupus erythematosus","volume":"49","author":"Hepburn","year":"2010","journal-title":"Rheumatology"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.74.3.163","article-title":"External ocular findings in lupus erythematosus: A clinical and immunopathological study","volume":"74","author":"Frith","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0186","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","article-title":"Systemic lupus erythematosus-associated optic neuritis: Clinical experience and literature review","volume":"87","author":"Lin","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0187","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s100670050069","article-title":"Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): Clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis","volume":"18","author":"Giorgi","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0188","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The american college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes ACR ad hoc committee on neuropsychiatric lupus nomenclature","volume":"42","author":"Gordon","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0189","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","article-title":"Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: Clinical, immunological, and radiological characteristics of 22 patients","volume":"39","author":"Espinosa","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0190","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.sult.2023.03.017_bib0191","doi-asserted-by":"crossref","unstructured":"T\u00e9llez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, et al. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. 2016;10(12):851-856. https:\/\/doi.org\/10.1191\/096120301701548490","DOI":"10.1191\/096120301701548490"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0192","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol Clin"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0193","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S2352-4642(22)00157-2","article-title":"Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus","volume":"6","author":"Appenzeller","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0194","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: A clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0195","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"16","author":"Costabel","year":"1999","journal-title":"Eur Respiratory J"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0196","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0197","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mcna.2018.12.011","article-title":"Sarcoidosis","volume":"103","author":"Llanos","year":"2019","journal-title":"Med Clin N Am"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0198","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccm.2015.08.002","article-title":"Genetics of sarcoidosis","volume":"36","author":"Fingerlin","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1053\/j.sult.2023.03.017_bib0199","doi-asserted-by":"crossref","unstructured":"Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis. 2012;170(12):1324-1330. https:\/\/doi.org\/10.1164\/RCCM.200402-249OC","DOI":"10.1164\/rccm.200402-249OC"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0200","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1183\/09031936.00002607","article-title":"Molecular evidence for the role of mycobacteria in sarcoidosis: A meta-analysis","volume":"30","author":"Gupta","year":"2007","journal-title":"Eur Respiratory J"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0201","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","article-title":"The immunology of sarcoidosis","volume":"29","author":"Gerke","year":"2008","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur Respiratory J"},{"key":"10.1053\/j.sult.2023.03.017_bib0203","doi-asserted-by":"crossref","unstructured":"Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. 2020;201(8):E26-E51. https:\/\/doi.org\/10.1164\/RCCM.202002-0251ST","DOI":"10.1164\/rccm.202002-0251ST"},{"issue":"29","key":"10.1053\/j.sult.2023.03.017_bib0204","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007595","article-title":"Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain","volume":"96","author":"Ma\u00f1\u00e1","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0206","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1183\/13993003.01369-2015","article-title":"Predictors of objective cough frequency in pulmonary sarcoidosis","volume":"47","author":"Sinha","year":"2016","journal-title":"Eur Respiratory J"},{"key":"10.1053\/j.sult.2023.03.017_bib0207","first-page":"794","article-title":"Acute and chronic sarcoid arthropathies: Characteristics and treatments from a retrospective nationwide French Study","volume":"7","author":"Cacciatore","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0208","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","article-title":"A review of the musculoskeletal manifestations of sarcoidosis","volume":"57","author":"Bechman","year":"2018","journal-title":"Rheumatology"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0209","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-0040-1713130","article-title":"Cutaneous Sarcoidosis","volume":"41","author":"Caplan","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0210","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Med"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-970335","article-title":"Extrapulmonary sarcoidosis","volume":"28","author":"Judson","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0212","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/practneurol-2019-002349","article-title":"Neurosarcoidosis: Clinical manifestations, investigation and treatment","volume":"20","author":"Kidd","year":"2020","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0214","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2019.10.001","article-title":"Sarcoidosis presenting with and without L\u00f6fgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691 patients","volume":"87","author":"Rubio-Rivas","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"20","key":"10.1053\/j.sult.2023.03.017_bib0215","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0216","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","article-title":"Clinical features and prognostic factors of spinal cord sarcoidosis: A multicenter observational study of 20 BIOPSY-PROVEN patients","volume":"263","author":"Durel","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0217","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1971400918806634","article-title":"Imaging findings in spinal sarcoidosis: A report of 18 cases and review of the current literature","volume":"32","author":"Soni","year":"2019","journal-title":"Neuroradiol J"},{"key":"10.1053\/j.sult.2023.03.017_bib0218","doi-asserted-by":"crossref","DOI":"10.1016\/j.acra.2023.01.017","article-title":"Immune-mediated hypertrophic pachymeningitis and its mimickers: Magnetic resonance imaging findings","author":"Matias","year":"2023","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0219","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1590\/0100-3984.2014.0113","article-title":"Central nervous system involvement in sarcoidosis","volume":"48","author":"Machado","year":"2015","journal-title":"Radiol Bras"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0220","first-page":"256","article-title":"Neurosarcoidosis: Pathophysiology, diagnosis, and treatment","volume":"8","author":"Giovannoni","year":"2021","journal-title":"Neurol(R) neuroimmunol neuroinflammation"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0221","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/NXI.0000000000000722","article-title":"Clinical and MRI phenotypes of sarcoidosis-associated myelopathy","volume":"7","author":"Murphy","year":"2020","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1053\/j.sult.2023.03.017_bib0222","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sj\u00f6gren's syndrome \u2013 Classification criteria and biomarkers","volume":"126","author":"Jonsson","year":"2018","journal-title":"Eur J Oral Sci"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0223","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: A systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.sult.2023.03.017_bib0224","doi-asserted-by":"crossref","unstructured":"Negrini S, Emmi G, Greco M, et al. Sj\u00f6gren's syndrome: A systemic autoimmune disease. 2022;22:9-25. https:\/\/doi.org\/10.1007\/s10238-021-00728-6","DOI":"10.1007\/s10238-021-00728-6"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome in a french multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0226","first-page":"S3","article-title":"One year in review 2020: Pathogenesis of primary Sj\u00f6gren's syndrome","volume":"38","author":"Bombardieri","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0227","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0002-9343(91)80007-9","article-title":"Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sj\u00f6gren's syndrome","volume":"90","author":"Mariette","year":"1991","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0228","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1006\/viro.1996.8352","article-title":"Epstein-Barr virus (EBV) infection in salivary gland tumors: Lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells","volume":"227","author":"Wen","year":"1997","journal-title":"Virology"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0229","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren's syndrome at 7q11.23","volume":"45","author":"Zhang","year":"2013","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rdc.2016.03.003","article-title":"Genetics in Sj\u00f6gren syndrome","volume":"42","author":"Reksten","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0231","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sj\u00f6gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0232","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1053\/j.sult.2023.03.017_bib0233","doi-asserted-by":"crossref","unstructured":"Patel R, Shahane A. Clinical epidemiology dovepress the epidemiology of Sj\u00f6gren's syndrome. Clin Epidemiol. 2014. 6:247-255, https:\/\/doi.org\/10.2147\/CLEP.S47399","DOI":"10.2147\/CLEP.S47399"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0234","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren's syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0236","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sj\u00f6gren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1053\/j.sult.2023.03.017_bib0237","doi-asserted-by":"crossref","unstructured":"Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sj\u00f6gren's syndrome. 2013. https:\/\/doi.org\/10.1007\/s11882-013-0357-9","DOI":"10.1007\/s11882-013-0357-9"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0238","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3899\/jrheum.141475","article-title":"Quality of sexual life in women with primary Sj\u00f6gren syndrome","volume":"42","author":"Priori","year":"2015","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0239","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e3182329d9c","article-title":"Gastrointestinal and hepatic manifestations of Sjogren syndrome","volume":"46","author":"Ebert","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0240","article-title":"Neurological disorders in primary Sj\u00f6gren's syndrome","author":"Tobn","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1053\/j.sult.2023.03.017_bib0241","doi-asserted-by":"crossref","unstructured":"Kim SM, Waters P, Vincent A, et al. Sj\u00f6gren's syndrome myelopathy: spinal cord involvement in Sj\u00f6gren's syndrome might be a manifestation of neuromyelitis optica. 2009;15(9):1062-1068. https:\/\/doi.org\/10.1177\/1352458509106636","DOI":"10.1177\/1352458509106636"},{"key":"10.1053\/j.sult.2023.03.017_bib0242","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-021-01000-2","article-title":"Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): An update for the rheumatologist","volume":"23","author":"Cruz","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1053\/j.sult.2023.03.017_bib0244","doi-asserted-by":"crossref","unstructured":"Javed A, Balabanov R, Arnason BGW, et al. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. 2008;14(6):809-814. https:\/\/doi.org\/10.1177\/1352458508088941","DOI":"10.1177\/1352458508088941"},{"issue":"8","key":"10.1053\/j.sult.2023.03.017_bib0245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbamem.2006.01.022","article-title":"Distribution and roles of aquaporins in salivary glands","volume":"1758","author":"Delporte","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"17","key":"10.1053\/j.sult.2023.03.017_bib0246","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: A new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0247","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 ACR-EULAR classification criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.sult.2023.03.017_bib0248","first-page":"247","article-title":"Refractory Sj\u00f6gren\u2019s syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report","volume":"6","author":"Ishikawa","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1053\/j.sult.2023.03.017_bib0249","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: A study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0250","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sj\u00f6gren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0252","first-page":"1","article-title":"Beh\u00e7et syndrome","volume":"7","author":"Yazici","year":"2021","journal-title":"Nature Rev Dis Primers"},{"issue":"2","key":"10.1053\/j.sult.2023.03.017_bib0253","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: A contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nature Rev Rheumatol"},{"issue":"7842","key":"10.1053\/j.sult.2023.03.017_bib0254","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","article-title":"Letter: HL-A5 and Beh\u00e7et's disease","volume":"2","author":"Ohno","year":"1973","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.berh.2011.05.002","article-title":"Beh\u00e7et's syndrome and micro-organisms","volume":"25","author":"Hatemi","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1053\/j.sult.2023.03.017_bib0256","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clim.2016.06.002","article-title":"Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Beh\u00e7et's disease","volume":"169","author":"Coit","year":"2016","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0257","first-page":"1","article-title":"The oral mucosal and salivary microbial community of Beh\u00e7et's syndrome and recurrent aphthous stomatitis","volume":"7","author":"Seoudi","year":"2015","journal-title":"J Oral Microbiol"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153746","article-title":"Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet's disease","volume":"11","author":"Shimizu","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.sult.2023.03.017_bib0259","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Beh\u00e7et's syndrome patients exhibit specific microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0260","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ni.3587","article-title":"Epithelial glycosylation in gut homeostasis and inflammation","volume":"17","author":"Goto","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1053\/j.sult.2023.03.017_bib0261","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/annrheumdis-2013-204475","article-title":"FUT2: filling the gap between genes and environment in Beh\u00e7et's disease?","volume":"74","author":"Xavier","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.sult.2023.03.017_bib0262","first-page":"338","article-title":"The International Criteria for Behc \u00dfet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"JEADV"},{"key":"10.1053\/j.sult.2023.03.017_bib0263","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/653806","article-title":"Musculoskeletal findings in Behcet's disease","author":"Bicer","year":"2012","journal-title":"Patholog Res Int"},{"issue":"11","key":"10.1053\/j.sult.2023.03.017_bib0264","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","article-title":"Vascular involvement in Beh\u00e7et's syndrome: A retrospective analysis of associations and the time course","volume":"53","author":"Tascilar","year":"2014","journal-title":"Rheumatology"},{"issue":"7","key":"10.1053\/j.sult.2023.03.017_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-018-0843-5","article-title":"Beh\u00e7et's Syndrome and Nervous System Involvement","volume":"18","author":"Uyguno\u011flu","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1053\/j.sult.2023.03.017_bib0266","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","article-title":"The spectrum of nervous system involvement in Beh\u00e7et\u2019s syndrome and its differential diagnosis","volume":"256","author":"Siva","year":"2009","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2023.03.017_bib0267","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117436","article-title":"An uncommon disease included commonly in the differential diagnosis of neurological diseases: Neuro-Beh\u00e7et's syndrome","volume":"426","author":"Uygunoglu","year":"2021","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1053\/j.sult.2023.03.017_bib0268","first-page":"S13","article-title":"One year in review 2018: Beh\u00e7et's syndrome","volume":"36","author":"Hatemi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1053\/j.sult.2023.03.017_bib0269","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ncl.2017.08.014","article-title":"Common clinical and imaging conditions misdiagnosed as multiple sclerosis: A current approach to the differential diagnosis of multiple sclerosis","volume":"36","author":"Siva","year":"2018","journal-title":"Neurol Clin"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217123000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217123000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:27:00Z","timestamp":1760135220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217123000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":269,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0887217123000410"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2023.03.017","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}